Abnormalities in neuronal circuits within frontal cortex, striatum, thalamus and amygdala represent a major component of the pathophysiologic state of schizophrenia. The identification of the molecular mechanisms of antipsychotic drugs has been greatly impaired by the impossibility of studying specific neuronal populations. This Conte Center proposes to address this issue by using a novel technology that precisely allows the analysis of individual types of neurons that are intricately mixed and anatomically indistinguishable. This multidisciplinary approach involves a number of repetitive tasks that can be efficiently conducted in a centralized structure such as a Core. Over the past 20 years, considerable experience has been acquired in the Greengard laboratory with the operation of such a facility. An important aspect of the Core will be to support the characterization of novel candidate genes identified. Such responsibilities will include the production and maintenance of key reagents stocks, the development of new reagents, and the performance of routine tasks.
Specific Aims i nclude: I. The generation, production, purification and characterization of polyclonal/monoclonal antibodies, including phosphorylation state-specific antibodies. The Core will support the entire program by generating various polyclonal and monoclonal antibodies. In addition, phospho-specific antibodies against key signaling molecules will be produced, tested, and purified as needed. II. The engineering and production of viral reagents required by Projects 1-5. The Core will design and generate the necessary AAV viral reagents in order to drive specific expression of siRNAs or protein overexpression in mouse lines that express the Cre recombinase in specific cell populations. III. The performance of routine tasks. This will include the preparation, purification and characterization of various kinases, phosphatases, and intracellular signaling molecules. The Core will perform, where needed, yeast two-hybrid studies. The Core personnel has also extensive experience in various other routine tasks such as cell culture preparation, immunofluorescence techniques, siRNA design and testing.

Public Health Relevance

to public health: Schizophrenia is a debilitating psychiatric disorder affecting ~1 % of the population. New therapeutic treatments for schizophrenia are needed. The Molecular &Biochemical Core will provide a common stock of the antibodies and reagents necessary for the work of all the Projects in this Conte Center Grant.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH090963-04
Application #
8475668
Study Section
Special Emphasis Panel (ZMH1-ERB-M)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
4
Fiscal Year
2013
Total Cost
$158,993
Indirect Cost
$59,174
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Milosevic, Ana; Liebmann, Thomas; Knudsen, Margarete et al. (2016) Cell- and region-specific expression of depression-related protein p11 (S100a10) in the brain. J Comp Neurol :
Xu, Jian; Kurup, Pradeep; Azkona, Garikoitz et al. (2016) Down-regulation of BDNF in cell and animal models increases striatal-enriched protein tyrosine phosphatase 61 (STEP61 ) levels. J Neurochem 136:285-94
Rapanelli, Maximiliano; Frick, Luciana R; Horn, Kyla D et al. (2016) The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons. J Biol Chem 291:21042-21052
Uematsu, Ken; Heiman, Myriam; Zelenina, Marina et al. (2015) Protein kinase A directly phosphorylates metabotropic glutamate receptor 5 to modulate its function. J Neurochem 132:677-86
Wang, Hong; Warner-Schmidt, Jennifer; Varela, Santiago et al. (2015) Norbin ablation results in defective adult hippocampal neurogenesis and depressive-like behavior in mice. Proc Natl Acad Sci U S A 112:9745-50
Snyder, Gretchen L; Vanover, Kimberly E; Zhu, Hongwen et al. (2015) Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission. Psychopharmacology (Berl) 232:605-21
Plattner, Florian; Hayashi, Kanehiro; Hernández, Adan et al. (2015) The role of ventral striatal cAMP signaling in stress-induced behaviors. Nat Neurosci 18:1094-100
Nakajima, Miho; Görlich, Andreas; Heintz, Nathaniel (2014) Oxytocin modulates female sociosexual behavior through a specific class of prefrontal cortical interneurons. Cell 159:295-305
Dietz, David M; Kennedy, Pamela J; Sun, Haosheng et al. (2014) ýýFosB induction in prefrontal cortex by antipsychotic drugs is associated with negative behavioral outcomes. Neuropsychopharmacology 39:538-44
Meyer, Douglas A; Torres-Altoro, Melissa I; Tan, Zhenjun et al. (2014) Ischemic stroke injury is mediated by aberrant Cdk5. J Neurosci 34:8259-67

Showing the most recent 10 out of 37 publications